Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-050677

Chief Executive Officer acquired 62,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Collard Craig A · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-03 Exercise or conversion : show line 1 in the form +62,500 377,367 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-04-03 Exercise or conversion : show line 2 in the form Restricted Stock Units −62,500 125,000 D
Loading xslF345X05/ownership.xml…